Biopharma Plastics Market Size, Share & Trends Analysis Report By Polymer Type, By Application, By Region And Segment Forecasts, 2022 - 2030
NEW YORK,Dec. 15, 2022/PRNewswire/ --
Biopharma Plastics Market Size, Share & Trends Analysis Report By Polymer Type (Polyvinyl Chloride, Polyethylene), By Application (Syringes, Containers), By Region, And Segment Forecasts, 2022 - 2030
Read the full report:https://www.reportlinker.com/p06373133/?utm_source=PRN
Biopharma Plastics Market Growth & Trends
The global biopharma plastics market size is expected to reachUSD 11.29 billionby 2030. The market is expected to expand at a CAGR of 11.2% from 2022 to 2030. The growing awareness about lightweight materials used in the healthcare industry in various applications such as containers, valves, and clamps is expected to drive the demand for silicones. Superior characteristics of the biopharma plastic polymers make them highly compatible with rubber, adhesives, metals, and coatings, thus increasing their preference over other products. Increasing production of biopharma plastic products is the key factor behind the growth of this market.
The revision of the regulatory framework associated with the biopharma industry is expected to increase the safety, efficacy, and performance standards of biopharma plastic-based medical products.As a result, the demand for superior-quality biopharma plastics is expected to grow inEuropein the coming years.
The market in the region is highly regulated, with stringent norms enforced for the production of biopharma plastics by the World Health Organization.
The growing demand for biopharma plastics to manufacture various medical equipment, such as drug delivery systems, beakers, test tubes, and containers for laboratory ware, IV, and dialysis fluid is expected to positively impact the growth of the market over the forecast period. The growing biopharma/medical industry coupled with the increasing demand for a hygienic and clean environment at healthcare facilities is expected to have a positive impact on the market growth over the forecast period.
The high demand for advanced healthcare services owing to the availability of well-developed healthcare infrastructure, increasing incidences of cardiovascular diseases, and rising aging population are anticipated to drive the demand for biopharma medical devices, which, in turn, is expected to drive polyethylene terephthalate demand in biopharma applications.
Biopharma Plastics Market Report Highlights
• In terms of revenue, the polyvinyl chloride polymer type segment accounted for a prominent share in 2021 and is expected to witness prominent growth over the forecast period
• The syringes application segment dominated the market and accounted for more than 20.0% share of the overall revenue in 2021. The increased demand for advanced healthcare services owing to surging incidences of cardiovascular diseases, orthopedic disorders, and endovascular diseases and expanding geriatric global population base is anticipated to drive the consumption of syringes in the market
• As of 2021,Asia Pacificaccounted for the largest share of more than 30.0% in terms of revenue. The presence of a well-established manufacturing base and increased healthcare expenditure inChina,Japan, andIndiaare anticipated to provide further impetus to the regional market growth
一个€¢主要参与者不断致力于产品开发loping their production plants owing to the increased usage of biopharma plastics in the healthcare industry. For instance, inApril 2022, Iktos and Teijin Limited co-developed a new technology for small molecule drug discovery. Under this agreement, Iktos and Teijin Pharma will collaborate to develop new AI technology with the goal of enhancing and speeding up the drug design process
Read the full report:https://www.reportlinker.com/p06373133/?utm_source=PRN
AboutReportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Contact Clare:[email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article